+$326.8M
Net Activity
Institutions Holding
230
Popularity Rank
#2563
Avg Weight
0.34%
Total Value
$2.3B
230 institutions currently hold CLDX, with 120 net buyers and 75 net sellers this quarter.
Institutional Moves (Q1 2026)
Majority Increased
Based on recent trading activity
Net Selling Institutions
75
Net Buying Institutions
120
Top 5 by Value
+$1.1B
Total Buy Value
$1.0B
Total Sell Value
120
Net Buyers
75
Net Sellers
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Celldex Therapeutics announced the planned retirement of its Chief Financial Officer, Sam Martin, effective on or about March 31, 2027. Martin, who has been with the company since 2009 and CFO since 2017, will remain in his role until a successor is appointed or his retirement date to ensure a smooth transition. The company has begun a search for a new CFO.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter